SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 138 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $76,000 | -93.4% | 58,745 | -93.6% | 0.00% | – |
| Q4 2021 | $1,157,000 | -40.8% | 910,909 | +1.6% | 0.00% | – |
| Q3 2021 | $1,955,000 | -41.4% | 896,475 | +0.7% | 0.00% | -100.0% |
| Q2 2021 | $3,339,000 | +24.5% | 890,342 | +8.2% | 0.00% | 0.0% |
| Q1 2021 | $2,682,000 | -10.1% | 822,556 | -5.9% | 0.00% | 0.0% |
| Q4 2020 | $2,982,000 | -14.5% | 874,514 | +2.3% | 0.00% | 0.0% |
| Q3 2020 | $3,488,000 | +42.3% | 854,734 | +17.9% | 0.00% | 0.0% |
| Q2 2020 | $2,451,000 | +43.5% | 725,176 | -1.1% | 0.00% | 0.0% |
| Q1 2020 | $1,708,000 | -28.8% | 733,125 | +11.2% | 0.00% | 0.0% |
| Q4 2019 | $2,400,000 | -56.8% | 659,217 | -1.6% | 0.00% | 0.0% |
| Q3 2019 | $5,555,000 | -13.0% | 669,703 | -9.7% | 0.00% | -50.0% |
| Q2 2019 | $6,384,000 | -40.3% | 741,498 | -25.9% | 0.00% | -50.0% |
| Q1 2019 | $10,696,000 | +11.7% | 1,000,594 | -8.6% | 0.00% | 0.0% |
| Q4 2018 | $9,577,000 | -58.1% | 1,094,481 | -19.5% | 0.00% | -42.9% |
| Q3 2018 | $22,852,000 | +44.9% | 1,360,241 | +80.8% | 0.01% | +40.0% |
| Q2 2018 | $15,771,000 | -19.8% | 752,408 | -38.5% | 0.01% | -28.6% |
| Q1 2018 | $19,671,000 | +40.6% | 1,222,526 | +65.5% | 0.01% | +40.0% |
| Q4 2017 | $13,994,000 | +152.7% | 738,472 | +87.7% | 0.01% | +150.0% |
| Q3 2017 | $5,537,000 | +216.0% | 393,459 | +67.4% | 0.00% | +100.0% |
| Q2 2017 | $1,752,000 | +22.9% | 235,105 | +7.2% | 0.00% | – |
| Q1 2017 | $1,425,000 | +49.8% | 219,223 | +2.1% | 0.00% | – |
| Q4 2016 | $951,000 | -70.9% | 214,667 | -69.3% | 0.00% | -100.0% |
| Q3 2016 | $3,269,000 | -25.4% | 699,892 | +4.9% | 0.00% | -50.0% |
| Q2 2016 | $4,384,000 | +96.4% | 667,368 | +90.1% | 0.00% | +100.0% |
| Q1 2016 | $2,232,000 | +53.3% | 351,000 | +45.4% | 0.00% | 0.0% |
| Q4 2015 | $1,456,000 | +7.6% | 241,392 | +6.7% | 0.00% | 0.0% |
| Q3 2015 | $1,353,000 | +1.9% | 226,259 | +16.5% | 0.00% | 0.0% |
| Q2 2015 | $1,328,000 | +27.1% | 194,137 | +12.7% | 0.00% | – |
| Q1 2015 | $1,045,000 | +2.1% | 172,225 | +16.6% | 0.00% | – |
| Q4 2014 | $1,024,000 | -18.6% | 147,712 | -4.4% | 0.00% | -100.0% |
| Q3 2014 | $1,258,000 | +3.3% | 154,574 | +3.2% | 0.00% | – |
| Q2 2014 | $1,218,000 | -10.9% | 149,838 | -14.0% | 0.00% | -100.0% |
| Q1 2014 | $1,367,000 | +7.5% | 174,316 | +21.2% | 0.00% | 0.0% |
| Q4 2013 | $1,272,000 | +13.7% | 143,769 | +7.7% | 0.00% | – |
| Q3 2013 | $1,119,000 | -92.3% | 133,538 | -93.1% | 0.00% | -100.0% |
| Q2 2013 | $14,447,000 | – | 1,936,614 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
| Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
| Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
| Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
| ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
| PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
| Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
| PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
| J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |